Marburg virus disease therapeutics sales will grow through 2036, led by antibiotics at 34.2% of the drug classification segment in 2026. The market was valued at USD 100.90 million in 2025 and is expected to be worth USD 172.57 million by 2036, creating an incremental opportunity of USD 66.62 million.